Dexamethasone for treatment of severe COVID-19, a surprise?

Dexamethasone for treatment of severe COVID-19, a surprise?

Bibliographic Details
Main Author:	Hany Hasan Elsayed
Format:	Article
Language:	English
Published:	SpringerOpen 2020-09-01
Series:	The Cardiothoracic Surgeon
Subjects:	COVID-19 ARDS Dexamethasone
Online Access:	http://link.springer.com/article/10.1186/s43057-020-00032-1

Similar Items

Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report
by: Jennifer Jacobson, et al.
Published: (2021-01-01)

Dexamethasone in severe COVID-19 infection: A case series
by: Mohamed Eliwa Hassan, et al.
Published: (2020-01-01)

Dexamethasone in the Treatment of COVID-19: Primus Inter Pares?
by: Vasiliki Romanou, et al.
Published: (2021-06-01)

Persistent hiccups after treatment of COVID-19 with dexamethasone: A case report
by: Sajad Karampoor, et al.
Published: (2021-01-01)

Extracorporeal membrane oxygenation (ECMO) in patients with severe COVID-19 adult respiratory distress syndrome: a systematic review and meta-analysis
by: Hany Hasan Elsayed, et al.
Published: (2021-04-01)

Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial
by: Jan Maláska, et al.
Published: (2021-03-01)

Dexamethasone as a Treatment of COVID-19
by: Abdullah Alkattan, et al.
Published: (2020-12-01)

The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
by: Heloísa Antoniella Braz-de-Melo, et al.
Published: (2021-04-01)

Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19?
by: Alexander Hooftman, et al.
Published: (2021-01-01)

Lung Targeted Lipopolymeric Microspheres of Dexamethasone for the Treatment of ARDS
by: Sabna Kotta, et al.
Published: (2021-08-01)

Tofacitinib as an Adjunct Immunomodulator for Treatment of a Patient with Severe COVID-19: A Case Report
by: Gentle Sunder Shrestha, et al.
Published: (2021-07-01)

Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study
by: Zarębska-Michaluk D, et al.
Published: (2021-07-01)

Evaluation of microcirculation disorders in patients with severe COVID-19 by nail bed capillaroscopy
by: Е. Е. Ladozhskaya-Gapeenko, et al.
Published: (2021-03-01)

Impact of dexamethasone use to prevent from severe COVID-19-induced acute kidney injury
by: Arthur Orieux, et al.
Published: (2021-07-01)

Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom
by: Luigino Calzetta, et al.
Published: (2021-04-01)

COVID-19 and HBOT: A conceptual standpoint
by: Gaurab Ghosh
Published: (2020-01-01)

Corticosteroids in the treatment of severe COVID-19 lung disease: The pulmonology perspective from the first United States epicenter
by: Precious Macauley, et al.
Published: (2020-11-01)

Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A case report
by: Hao-Yu Wu, et al.
Published: (2021-09-01)

Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome
by: François Bagate, et al.
Published: (2020-11-01)

Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
by: Keivan Ranjbar, et al.
Published: (2021-04-01)

Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap
by: Lucia Gozzo, et al.
Published: (2020-11-01)

COVID-19 acute respiratory distress syndrome: can iloprost have a role for the treatment?
by: Alida Filippini, et al.
Published: (2021-01-01)

COVID-19 pneumonia: ARDS or not?
by: Luciano Gattinoni, et al.
Published: (2020-04-01)

Major bleeding after pronation in severe COVID-19 patient
by: Rosanna Carmela De Rosa, et al.
Published: (2021-02-01)

COVID-19 ARDS: A Multispecialty Assessment of Challenges in Care, Review of Research, and Recommendations
by: Shibu Sasidharan, et al.
Published: (2021-01-01)

Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?
by: Claudio Ortolani, et al.
Published: (2020-09-01)

Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy
by: Ivan G. Shabalin, et al.
Published: (2020-11-01)

Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
by: Janine Alessi, et al.
Published: (2020-09-01)

Clinical Course and Outcomes of Severe Covid-19: A National Scale Study
by: Moran Amit, et al.
Published: (2020-07-01)

Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death
by: Laszlo Szekely, et al.
Published: (2021-05-01)

Assessment of pulmonary surfactant in COVID-19 patients
by: Peter Schousboe, et al.
Published: (2020-09-01)

Mesenchymal stem cells as a potential therapy for COVID-19
by: Shan Liu, et al.
Published: (2020-05-01)

Acute Pancreatitis and COVID-19: A Single-Center Experience
by: Annunziata A, et al.
Published: (2021-10-01)

Acute lung injury in patients with COVID‐19 infection
by: Liyang Li, et al.
Published: (2020-03-01)

DEXAMETHASONE USE IN MANAGEMENT OF COVID19: A REVIEW
by: Samer Mohammed
Published: (2021-03-01)

Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone
by: Chrysi Keskinidou, et al.
Published: (2021-07-01)

Factors determining ARDS and mortality in Covid-19 pneumonia
by: Hüseyin Acar, et al.
Published: (2021-05-01)

COVID-19 pneumonia: phenotype assessment requires bedside tools
by: Zhanqi Zhao, et al.
Published: (2020-05-01)

Chest Pain in COVID-19 Patients May not Refer to Cardiac Ischemia
by: Entezar Mehrabi Nasab, et al.
Published: (2020-07-01)

Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study
by: Andrea Carta, et al.
Published: (2021-09-01)

Cannot write session to /tmp/vufind_sessions/sess_e1sk7cp75fojpbjp3snsn0s13e